Our study suggests that factors such as post-menopausal status, Hispanic/Arabic ethnicity, and the ER+/HER2+ tumor subtype could serve as key variables to guide the need for screening aimed at early BM detection. The gene discussed is ERBB2; the disease is neoplasm.